REVBW
Revelation Biosciences, Inc.
Set alert
0.01 USD 0.00 0.00%
0.0053 Day range 0.0057
0.0057 52-week range 0.0057
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0125
- Prev close
- 0.0057
- Mkt cap
- 31.40K
- Vol
- 23.25K
- Avg vol
- 0
- EPS
- -4.77
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0053
- High
- 0.0057
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-3928.55 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2019 5y median -4.0× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 0.2×
FY 2019 5y median 3.2× FY 2025
P/FCF -0.2×
FY 2019 5y median -3.8× FY 2025
EV/EBITDA 0.9×
FY 2019 5y median -3.4× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -416.3%
FY 2019 5y median -26.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -100.6%
FY 2019 5y median -100.6% FY 2025
ROIC -94.4%
FY 2019 5y median -130.2% FY 2025
ROA -77.0%
FY 2019 5y median -196.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -13.7%
FY 2019 FY 2025
EPS (diluted) 72.7%
FY 2019 FY 2025
Free Cash Flow 54.9%
FY 2019 FY 2025
Financial Health
Current Ratio 5.4×
FY 2019 5y median 2.2× FY 2025
Quick Ratio 5.4×
FY 2019 5y median 2.2× FY 2025
Debt / Equity 0.1×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.1×
FY 2019 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31